GlycoNet Integrated Services (GIS) is a pan-Canadian initiative managed by the Canadian Glycomics Network (GlycoNet), uniting expertise, state-of-the-art technologies, and infrastructure from leading research institutions to drive innovation in glycomics and glycoscience.
Our mission is to accelerate the discovery, development, and commercialization of solutions for critical challenges in healthcare, agriculture, and environmental sustainability.
GIS is supported in part by the Canada Foundation for Innovation’s Major Science Initiatives Fund (2023-2029) and Genome Canada’s Technology Development Program (2023-2026).
Comprehensive Glycomics Services
Extraordinary Expertise.
State-of-the-Art.
Comprehensive.
Our advanced instruments and technologies,
combined with the expertise of our scientific and technical teams,
ensure reliable, high-quality services for all clients.
Download Our Brochure to learn more about our facilities and services.
View webinars from some of our researchers:
Why Choose GIS?
GIS integrates the knowledge and resources of seven regional centres across Canada, offering a comprehensive platform for glycomics research and development. Our team has a proven track record in method and technology innovation, demonstrated by contributions such as:
- Glycoengineered therapeutic proteins (Sim et al., 2022, Glycobiology)
- Liquid glycan array (Sojitra et al., 2021, Nature Chemical Biology)
- Complex glycan synthesis (Lin et al., 2020, Organic Letters)
- High-throughput antibiotics discovery (Klobucar et al., 2021, ACS Chemical Biology)
- Tandem metabolic engineering (Zhu et al., 2020, Journal of American Chemical Society)
- Quantitative mass spectrometry-coupled binding assays (Bolivar et al., 2021, Analytical Chemistry)
- Lectin microarray (Heindel et al., 2020, Proceedings of the National Academy of Sciences of the United States of America).
- High-Throughput Screen for oprF in Biofilm Stimulation by Subinihibory Antibiotics (Yaeger LN et al., 2024, npj Biofilms and Microbiomes).
- Production of Recombinant Proteins (Ma et al., 2024, Journal of American Chemical Society)
- Quantification of Binding Affinities Using Native Mass Spectrometry-Coupled Assays (Bui et al., 2024, Journal of the American Chemical Society)
In addition to biomedical research and biotechnology, GIS supports advancements in agriculture, plant biotechnology, biomaterials, biofuels, environmental research, and disease surveillance.
About the Facility
GIS operates as a fully integrated national platform, with facilities located in:
Montreal (Research Institute of the McGill University Health Centre, INRS, CHU Ste-Justine)
Hamilton (McMaster University)
Edmonton (University of Alberta)
Burnaby (Simon Fraser University)
GIS enhances global biotechnology capacity by driving discoveries, fostering international collaboration and delivering advanced glycomics solutions. By addressing pressing challenges in healthcare, agriculture, and environmental sustainability, GIS contributes meaningfully to achieving One Health and Sustainable Development Goals (SDGs).
The nodes of the facility are across seven institutions in Canada.
Get Started With GIS
Contact GIS to advance your research and development. Email us your questions at coreservices@glyconet.ca
Learn more about our Process for Service Requests